Back
Telomir Pharmaceuticals 10K Form
Sell
39
TELO
Telomir Pharmaceuticals
Last Price:
6.01
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TELO News And Ratings
See the #1 stock for the next 7 days that we like better than TELO
TELO Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-1.94M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.10 |
| Price / Book: | 60.66 |
Profitability
| EPS (TTM): | -0.65520 |
|---|---|
| Net Income (TTM): | $-18.84M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Telomir Pharmaceuticals Earnings Forecast
Key Telomir Pharmaceuticals Financial Ratios
- The Interest Expense is -12.57% of Operating Income.
- Per Share Earnings over the last 3 years have been positive in 0 years.
Telomir Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TELO |
| Website: | telomirpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TELO Technical Analysis vs Fundamental Analysis
Sell
39
Telomir Pharmaceuticals (TELO)
is a Sell
Is Telomir Pharmaceuticals a Buy or a Sell?
-
Telomir Pharmaceuticals stock is rated a Sell
The current Telomir Pharmaceuticals [TELO] share price is $6.18. The Score for TELO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.